See clinical trial results of Flebogamma® DIF in: Primary immunodeficiency Autoimmune Disease
Flebogamma® DIF 5% may be an appropriate choice for many of your patients, including those who cannot tolerate a 10% IVIG solution In a recent trial, only 2.2% of infusions with Flebogamma® DIF (...)
Flebogamma® DIF has been shown to be a safe and effective treatment for primary immunodeficiency and autoimmune disease.
Flebogamma DIF makes the Difference feature
Sign up to receive more information about Flebogamma® DIF